Antigenics Inc
OTC:ANTI
Antigenics Inc
OTC:ANTI
Price:
0
USD
Market Cap:
$0
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Antigenics Inc
OTC:ANTI
|
US |
|
Gaxos.AI Inc
NASDAQ:GXAI
|
US |
|
X
|
Xebra Brands Ltd
CNSX:XBRA
|
CA |
|
V
|
Vikas Lifecare Ltd
BSE:542655
|
IN |
|
Bridgestone Corp
TSE:5108
|
JP |
|
T
|
Tien Len Steel Corporation JSC
VN:TLH
|
VN |
|
P
|
Pangenomic Health Inc
CNSX:NARA
|
CA |
Balance Sheet
Balance Sheet Decomposition
Antigenics Inc
Antigenics Inc
Balance Sheet Decomposition is not available for
Antigenics Inc
Antigenics Inc
Balance Sheet
Antigenics Inc
Antigenics Inc
Currency: USD
| Dec-1991 | Dec-1992 | Dec-1993 | Dec-1994 | Dec-1995 | Dec-1996 | Dec-1997 | Dec-1998 | Dec-1999 | Dec-2000 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
2
|
1
|
12
|
1
|
8
|
4
|
2
|
11
|
12
|
8
|
|
| Cash Equivalents |
2
|
1
|
12
|
1
|
8
|
4
|
2
|
11
|
12
|
8
|
|
| Short-Term Investments |
1
|
8
|
8
|
7
|
2
|
30
|
18
|
8
|
8
|
0
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
3
|
9
|
20
|
9
|
11
|
35
|
20
|
19
|
20
|
8
|
|
| PP&E Net |
0
|
1
|
1
|
2
|
3
|
2
|
1
|
2
|
2
|
2
|
|
| PP&E Gross |
0
|
1
|
1
|
2
|
3
|
2
|
1
|
2
|
2
|
2
|
|
| Accumulated Depreciation |
0
|
0
|
1
|
1
|
2
|
3
|
4
|
3
|
3
|
4
|
|
| Long-Term Investments |
0
|
0
|
0
|
2
|
2
|
7
|
10
|
1
|
1
|
1
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
3
N/A
|
10
+205%
|
21
+103%
|
13
-39%
|
16
+20%
|
44
+185%
|
32
-27%
|
23
-28%
|
23
-1%
|
11
-51%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
0
|
0
|
1
|
1
|
2
|
1
|
2
|
5
|
4
|
3
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
2
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
2
|
2
|
0
|
1
|
|
| Total Current Liabilities |
0
|
1
|
1
|
1
|
2
|
4
|
5
|
8
|
4
|
5
|
|
| Long-Term Debt |
0
|
1
|
1
|
1
|
1
|
0
|
0
|
1
|
4
|
3
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
1
N/A
|
1
+80%
|
2
+45%
|
2
+34%
|
4
+54%
|
4
+8%
|
5
+25%
|
9
+99%
|
8
-15%
|
8
+5%
|
|
| Equity | |||||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
7
|
11
|
18
|
27
|
44
|
52
|
69
|
87
|
102
|
119
|
|
| Additional Paid In Capital |
10
|
22
|
38
|
38
|
56
|
94
|
97
|
101
|
113
|
119
|
|
| Unrealized Security Profit/Loss |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
0
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Equity |
0
|
1
|
1
|
1
|
0
|
1
|
0
|
0
|
1
|
3
|
|
| Total Equity |
3
N/A
|
9
+235%
|
19
+111%
|
11
-45%
|
12
+13%
|
40
+237%
|
27
-32%
|
14
-50%
|
15
+8%
|
3
-82%
|
|
| Total Liabilities & Equity |
3
N/A
|
10
+205%
|
21
+103%
|
13
-39%
|
16
+20%
|
44
+185%
|
32
-27%
|
23
-28%
|
23
-1%
|
11
-51%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
3
|
3
|
5
|
5
|
10
|
15
|
15
|
16
|
23
|
26
|
|
Switch to:
Switch to:
See Also
Discover More
